Datasets:
Add 40166195_01 test_case.json
Browse files
data/40166195_01/test_case.json
ADDED
|
@@ -0,0 +1,31 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"benchmark_id": "40166195_01",
|
| 3 |
+
"sample_system": "",
|
| 4 |
+
"tissue": "Breast",
|
| 5 |
+
"source_type": "cell_line",
|
| 6 |
+
"perturbation_type": "drug",
|
| 7 |
+
"perturbation_name": "doxorubicin",
|
| 8 |
+
"default_cell_subset": "",
|
| 9 |
+
"description": "MDA-MB-231 triple-negative breast cancer cells treated with doxorubicin and profiled by scRNA-seq after recovery.",
|
| 10 |
+
"smiles": "CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O",
|
| 11 |
+
"test_cases": [
|
| 12 |
+
{
|
| 13 |
+
"test_id": "40166195_01_01",
|
| 14 |
+
"target_genes": [
|
| 15 |
+
"PCSK6",
|
| 16 |
+
"LDLRAD4",
|
| 17 |
+
"SAMD5"
|
| 18 |
+
],
|
| 19 |
+
"perturb_var": "time",
|
| 20 |
+
"control": "C",
|
| 21 |
+
"dose_groups": [
|
| 22 |
+
"400 nM"
|
| 23 |
+
],
|
| 24 |
+
"time_groups": [
|
| 25 |
+
"~50 days"
|
| 26 |
+
],
|
| 27 |
+
"relation": "UP",
|
| 28 |
+
"cell_type": "MDA-MB-231 triple-negative breast cancer cell line"
|
| 29 |
+
}
|
| 30 |
+
]
|
| 31 |
+
}
|